Le Lézard
Classified in: Science and technology, Business
Subject: PVP

Fineqia Closes 2nd Tranche of Private Placement, Adding Momentum to Company's Growth


VANCOUVER, BC, Aug. 15, 2023 /PRNewswire/ - Fineqia International Inc. (the "Company" or "Fineqia") (CSE: FNQ) (OTC: FNQQF) (Frankfurt: FNQA) the digital asset and fintech investment business, announces the second tranche (the "Second Tranche") of its non-brokered private placement (the "Offering"), for a cumulative raise of C$309,696.

The Company has issued 30,969,600 Units to raise gross proceeds of C$308,996 and payment of finder's fees worth C$700 in this tranche. This follows the closure of the Company's first tranche, announced on June 30, which issued 58,527,500 units (the "Units") to raise gross proceeds of C$585,275 in the first tranche of the private placement and payment of finder's fees worth C$9,469.25, for a cumulative issuance of C$594,744.25 worth of units.

"Marking another milestone on our journey, Fineqia is excited to announce the successful closure of our second tranche of private placement, said Bundeep Singh Rangar, CEO of Fineqia. We are grateful for the continued trust and support of our investors, which fuels our drive to reshape the future of finance."

The final closure of the private placement is extended until September 15, allowing Fineqia to accommodate investors amidst the challenges posed by the summer holiday season. This extension ensures that interested parties have ample time to participate in this investment opportunity.

Each Unit sold or to be sold in the Offering consists of one common share of the Company priced at C$0.01 and one share purchase warrant (a "Warrant") exercisable for three years at a price of C$0.05 per share.

The Company may, at its option, accelerate the expiry date of the Warrants, provided that the closing price of the common shares is at or above C$0.10 per share for any 20 consecutive trading day period at any time after four months and one day after the issuance of the Warrants. Warrant holders will be notified by the issue of a press release by the Company announcing such acceleration. In such a situation, the expiry date shall be deemed to be the 20th day following the date of issuance of the press release.

The proceeds from the Offering will be used to enhance the Company's working capital.

These securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act"). Accordingly, these securities may not be offered or sold in the United States or to, or for the account or benefit of, a U.S. person or person in the United States (as such terms are defined in regulations under the 1933 Act), absent an exemption from the registration requirements of the 1933 Act and applicable state laws. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Fineqia International Inc.

Fineqia (www.fineqia.com) is a digital asset business that builds and targets investments in early and growth-stage technology companies that will be part of the next generation of the Internet. It also provides a platform to support and manage the issuance of debt securities in the UK. Publicly listed in Canada (CSE: FNQ) with offices in Vancouver and London, Fineqia's portfolio of investments includes businesses at the forefront of tokenization, blockchain technology, NFTs, AI, and fintech.

FORWARD-LOOKING STATEMENTS

Some statements in this release may contain forward-looking information (as defined under applicable Canadian securities laws) ("forward-looking statements"). All statements, other than of historical fact, that address activities, events or developments that Fineqia (the "Company") believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Any forward-looking statement speaks only as of the date on which it is made except as may be required by applicable securities laws. The Company disclaims any intent or obligation to update any forward-looking statement except to the extent required by applicable securities laws.

SOURCE Fineqia International Inc.


These press releases may also interest you

at 15:06
As law enforcement...

at 15:00
Greenlite Ventures, Inc. has announced the signing of an Acquisition Agreement with No Limit Technology Holdings, Inc. (NLTH), an emerging powerhouse in the Sports Betting arena. The Agreement is scheduled to be finalized following a 30?45-day due...

at 14:55
mdf commerce inc. ("mdf" or the "Company") , a SaaS leader in digital commerce technologies, is pleased to announce the closing of the previously announced plan of arrangement under the Canada Business Corporations Act (the "Arrangement") involving...

at 14:35
GEP®, a leading provider of AI-driven procurement and supply chain software and services to Fortune 500 and Global 2000 enterprises, won the top honor at the World Procurement Awards in London last night for Best Procurement Consultancy and, at the...

at 14:33
A study published today in Nature Medicine found that a novel neuroprotective drug candidate, LM11A-31, was safe and well-tolerated following dosing for 26 weeks in patients with mild to moderate Alzheimer's disease. LM11A-31 also slowed the...

at 14:25
Provation, the leading provider of healthcare software and SaaS solutions for clinical productivity, has announced its partnership with Al Naghi Medical Company LLC, a market leader in medical device and software distribution in the United Arab...



News published on and distributed by: